ZYME Income Statement (2021-2025) | ZYME

Income Statement Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue (Quarter) 8.00M325.00M4.50M1.00M8.00M3.10M48.73M
Operating items
Research & Development (Quarter) 29.16M34.45M
Selling, General & Administrative (Quarter) 15.68M14.95M
Other Operating Expenses (Quarter) 5.27M2.81M
Operating Expenses (Quarter) 62.13M49.40M
Operating Income (Quarter) -42.89M-0.67M
EBIT (Quarter) -42.89M-0.67M
Non-operating items
Interest & Investment Income (Quarter) 5.15M3.43M
Non Operating Income (Quarter) 0.11M-0.62M
Net income details
EBT (Quarter) -37.62M2.13M
Tax Provisions (Quarter) 0.07M-0.19M
Profit After Tax (Quarter) -31.65M-37.69M-22.64M2.32M
Income from Continuing Operations (Quarter) -37.69M2.32M
Consolidated Net Income (Quarter) -37.69M2.32M
Income towards Parent Company (Quarter) -37.69M2.32M
Net Income towards Common Stockholders (Quarter) -37.69M2.32M
Additional items
EPS (Basic) (Quarter) -0.490.03
EPS (Weighted Average and Diluted) (Quarter) -0.490.03
Shares Outstanding (Weighted Average) (Quarter) 51.55M61.37M63.87M64.75M65.19M66.74M67.28M70.58M68.86M76.21M76.30M76.24M75.85M75.17M75.25M75.77M
Shares Outstanding (Diluted Average) (Quarter) 52.13M65.25M68.86M76.40M75.88M75.30M
EBITDA (Quarter) -37.87M2.38M
Tax Rate (Quarter) -0.18%-8.73%